Cafepharma Today

May 16 2025 - Novo CEO to depart as obesity drugmaker’s challenges rise
Novo CEO to depart as obesity drugmaker’s challenges rise
BioMarin expands enzyme expertise with $270M Inozyme buy
Amgen could owe Regeneron more than $400M after defeat in cholesterol drug antitrust suit
Eli Lilly collaborates with Rznomics on hearing loss treatment in $1.3 billion pact
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Eurand says FDA approved pancreatic enzyme Zenpep
Yahoo/AP
Friday, August 28, 2009 - 11:59am
tags:
Aptalis, FDA, enzymes, Zenpep
Hisamitsu completes Noven acquisition
Bizjournals.com
Friday, August 28, 2009 - 11:12am
tags:
Hisamitsu, Noven, M&A
Takeda starting cardiovascular trial on diabetes drug SYR-322
Pharma Times, UK
Friday, August 28, 2009 - 7:28am
tags:
Takeda, diabetes, drug trials, SYR-322
Nycomed Smoker’s Cough Drug Helps Lung Function, Studies Show
Bloomberg
Friday, August 28, 2009 - 7:25am
tags:
Nycomed, smoker's cough, Daxas
Drug, Biotech Research Spending Hangs Tough
Businessweek
Thursday, August 27, 2009 - 10:32pm
tags:
R&D
Durect signs deal to supply King Pharmaceuticals with painkiller Remoxy
Yahoo/AP
Thursday, August 27, 2009 - 4:29pm
tags:
Durect Corporation, painkillers, Remoxy, King
Lonza: Patheon Bid Still Holds, Seeks JLL Talks
WSJ Online
Thursday, August 27, 2009 - 4:27pm
tags:
Lonza, Patheon
Will new label help Bristol's Orencia?
Fierce Pharma
Thursday, August 27, 2009 - 4:24pm
tags:
Bristol-Myers Squibb, Orencia
Setback for Alkermes' Pipeline
Yahoo/Zacks.com
Thursday, August 27, 2009 - 4:20pm
tags:
pipelines, Alkermes, Ortho-McNeil-Janssen, Risperdal Consta
Twin Problems for J&J
Yahoo/Zacks.com
Thursday, August 27, 2009 - 4:17pm
tags:
JNJ, Intelence, Ertaczo
Gene variation strongly predicts Plavix response
Reuters
Thursday, August 27, 2009 - 9:49am
tags:
Plavix, Bristol-Myers Squibb, Sanofi, blood thinners
Genzyme Appears Overbought: Reiterating Near-Term Sell
Seeking Alpha
Thursday, August 27, 2009 - 9:48am
tags:
Genzyme
Cryo-Cell: The Stem Cell Sector's Profit Leader,
Seeking Alpha
Thursday, August 27, 2009 - 9:43am
tags:
stem cells, Cryo-Cell, Geron, Osiris Therapeutics, StemCells
Bristol-Myers completes initial Medarex offer
Yahoo/AP
Thursday, August 27, 2009 - 9:34am
tags:
Medarex, Bristol-Myers Squibb, M&A
Abbott, Pfizer in pact for lung cancer screening
CNBC
Thursday, August 27, 2009 - 9:32am
tags:
lung cancer, Pfizer, Abbott Laboratories, partnerships
UCB, Immunomedics drug shows promise for lupus
Reuters
Thursday, August 27, 2009 - 9:17am
tags:
UCB Pharmaceuticals, Immunomedics, lupus
BioDelivery Sciences Can Now Be Considered a Long Term Growth Stock
Seeking Alpha
Thursday, August 27, 2009 - 9:17am
tags:
BioDelivery Sciences
Cell Therapeutics Could Be a Real Winner, But Not Right Now
Seeking Alpha
Thursday, August 27, 2009 - 8:30am
tags:
Cell Therapeutics, cancer
Geron Comments on FDA Hold on Spinal Cord Injury Trial
Yahoo
Thursday, August 27, 2009 - 8:17am
tags:
Geron, FDA, drug trials
Alkermes says Johnson & Johnson ended development of monthly Risperdal Consta injection
Yahoo/AP
Thursday, August 27, 2009 - 8:16am
tags:
Alkermes, JNJ, Risperdal Consta, antipsychotics

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Alzheimer's Update: Infectious Agents and Gamma-Secretase Too
In the Pipeline
Obesity Without Metabolic Dysfunction?
In the Pipeline
New Cell Therapy For Resistant Hodgkins Patients
In the Pipeline
Escape From the Lysosome
In the Pipeline
Heavy Water in Your NMR Experiments, And Elsewhere
In the Pipeline
GIPR: Agonists and Antagonists Do the Same Thing, But How
In the Pipeline
Mutant Proteins Classified
In the Pipeline
The Continuing Crisis, Part XIV: The Trumpist Worldview
In the Pipeline
Whole Lotta Snakin' Going On
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.